AAAAAA
Results: 1-25/60
Authors:
Dahl, SG
Allain, P
Marie, PJ
Mauras, Y
Boivin, G
Ammann, P
Tsouderos, Y
Delmas, PD
Christiansen, C
Citation: Sg. Dahl et al., Incorporation and distribution of strontium in bone, BONE, 28(4), 2001, pp. 446-453
Authors:
Lund-Hansen, LC
Christiansen, C
Laima, MJC
Citation: Lc. Lund-hansen et al., A new video controlled, hydraulically damped corer for sediment/water interaction studies, MAR GEORES, 19(3), 2001, pp. 147-154
Authors:
Bjarnason, NH
Riis, BJ
Christiansen, C
Citation: Nh. Bjarnason et al., The effect of fluvastatin on parameters of bone remodeling, OSTEOPOR IN, 12(5), 2001, pp. 380-384
Authors:
Reginster, JY
Christiansen, C
Roux, C
Fechtenbaum, J
Rouillon, A
Tou, KP
Citation: Jy. Reginster et al., Intermittent cyclic tiludronate in the treatment of osteoporosis, OSTEOPOR IN, 12(3), 2001, pp. 169-177
Authors:
Riis, BJ
Ise, J
Von Stein, T
Bagger, Y
Christiansen, C
Citation: Bj. Riis et al., Ibandronate: A comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis, J BONE MIN, 16(10), 2001, pp. 1871-1878
Authors:
Weyerstahl, P
Marschall, H
Christiansen, C
Citation: P. Weyerstahl et al., Constituents of the acidic part of commercial Brazilian lantana oil, FLAV FRAG J, 16(1), 2001, pp. 50-60
Authors:
Christiansen, C
Citation: C. Christiansen, Hormone replacement therapy for the postmenopausal woman, MATURITAS, 38, 2001, pp. S1-S5
Authors:
Jacobsen, PB
Oulie, I
Christiansen, C
Skotland, T
Citation: Pb. Jacobsen et al., Investigation of binding of I-125-iodixanol to high molecular weight substances after incubation with rat liver homogenates, ACT RADIOL, 42(1), 2001, pp. 117-120
Authors:
Bonder, B
Christiansen, C
Citation: B. Bonder et C. Christiansen, Editorial: Coming of age in challenging times (vol 21, pg 3, 2001), OCCUP THER, 21(2), 2001, pp. NIL_2-NIL_2
Authors:
Bonder, B
Christiansen, C
Citation: B. Bonder et C. Christiansen, Editorial: Coming of age in challenging times, OCCUP THER, 21(1), 2001, pp. 3-11
Authors:
Christiansen, C
Lou, JQ
Citation: C. Christiansen et Jq. Lou, Evidence-based practice forum - Ethical considerations related to evidence-based practice, AM J OCCU T, 55(3), 2001, pp. 345-349
Authors:
Reginster, JY
Henrotin, Y
Christiansen, C
Gamwell-Henriksen, E
Bruyere, O
Collette, J
Christgau, S
Citation: Jy. Reginster et al., Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I, CALCIF TIS, 69(3), 2001, pp. 130-137
Authors:
Alexandersen, P
Toussaint, A
Christiansen, C
Devogelaer, JP
Roux, C
Fechtenbaum, J
Gennari, C
Reginster, JY
Citation: P. Alexandersen et al., Ipriflavone in the treatment of postmenopausal osteoporosis - A randomizedcontrolled trial, J AM MED A, 285(11), 2001, pp. 1482-1488
Authors:
Alexandersen, P
Riis, BJ
Stakkestad, JA
Delmas, PD
Christiansen, C
Citation: P. Alexandersen et al., Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy, J CLIN END, 86(2), 2001, pp. 755-760
Authors:
Bjarnason, NH
Haarbo, J
Byrjalsen, I
Alexandersen, P
Kauffman, RF
Christiansen, C
Citation: Nh. Bjarnason et al., Raloxifene and estrogen reduces progression of advanced atherosclerosis - a study in ovariectomized, cholesterol-fed rabbits, ATHEROSCLER, 154(1), 2001, pp. 97-102
Authors:
Bergo, HO
Christiansen, C
Citation: Ho. Bergo et C. Christiansen, Determination of low levels of protein impurities in phospholipid samples, ANALYT BIOC, 288(2), 2001, pp. 225-227
Authors:
Bjarnason, NH
Christiansen, C
Citation: Nh. Bjarnason et C. Christiansen, Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women, BONE, 26(6), 2000, pp. 561-569
Authors:
Byrjalsen, I
Alexandersen, P
Christiansen, C
Citation: I. Byrjalsen et al., Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium, BR J OBST G, 107(3), 2000, pp. 347-355
Authors:
Alexandersen, P
Byrjalsen, I
Christiansen, C
Citation: P. Alexandersen et al., Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects, BR J OBST G, 107(3), 2000, pp. 356-364
Authors:
Bauer, M
Thabault, P
Estok, D
Christiansen, C
Platt, R
Citation: M. Bauer et al., Low-dose corticosteroids and avascular necrosis of the hip and knee, PHARMA D S, 9(3), 2000, pp. 187-191
Authors:
Christiansen, C
Pichler, WJ
Skotland, T
Citation: C. Christiansen et al., Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations, EUR RADIOL, 10(12), 2000, pp. 1965-1975
Authors:
Purdy, S
Finkelstein, JA
Fletcher, R
Christiansen, C
Inui, TS
Citation: S. Purdy et al., Patient participation in research in the managed care environment: Key perceptions of members in an HMO, J GEN INT M, 15(7), 2000, pp. 492-495
Authors:
Markovic, N
Christiansen, C
Mack, A
Goldman, AM
Citation: N. Markovic et al., Superconductor-insulator transitions in 2D: The experimental situation, PHYS ST S-B, 218(1), 2000, pp. 221-227
Authors:
Bjarnason, NH
Haarbo, J
Byrjalsen, I
Kauffman, RF
Knadler, MP
Christiansen, C
Citation: Nh. Bjarnason et al., Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol-fed rabbits, CLIN ENDOCR, 52(2), 2000, pp. 225-233
Authors:
Ekstrand, K
Christiansen, C
Christiansen, J
Citation: K. Ekstrand et al., Cost minimisation analysis of two occlusal caries preventive programmes, COMM DENT H, 17(4), 2000, pp. 260-260